| Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis ES Mearns, DM Sobieraj, CM White, WJ Saulsberry, CG Kohn, Y Doleh, ... PloS one 10 (4), e0125879, 2015 | 170 | 2015 |
| Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression ES Mearns, CM White, CG Kohn, J Hawthorne, JS Song, J Meng, ... Thrombosis journal 12, 1-20, 2014 | 130 | 2014 |
| Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis CG Kohn, ES Mearns, MW Parker, AV Hernandez, CI Coleman Chest 147 (4), 1043-1062, 2015 | 114 | 2015 |
| Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences JR Schein, CM White, WW Nelson, J Kluger, ES Mearns, CI Coleman Thrombosis journal 14, 1-10, 2016 | 77 | 2016 |
| Neurological manifestations of neuropathy and ataxia in celiac disease: A systematic review ES Mearns, A Taylor, KJ Thomas Craig, S Puglielli, AB Cichewicz, ... Nutrients 11 (2), 380, 2019 | 76 | 2019 |
| Diagnosis and treatment patterns in celiac disease AB Cichewicz, ES Mearns, A Taylor, T Boulanger, M Gerber, DA Leffler, ... Digestive diseases and sciences 64, 2095-2106, 2019 | 73 | 2019 |
| Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients ES Mearns, CG Kohn, JS Song, J Hawthorne, J Meng, CM White, ... Thrombosis research 134 (2), 310-319, 2014 | 65 | 2014 |
| Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta‐analysis ES Mearns, WJ Saulsberry, CM White, CG Kohn, S Lemieux, A Sihabout, ... Diabetic Medicine 32 (12), 1530-1540, 2015 | 56 | 2015 |
| Prevalence of Community-Acquired Methicillin-Resistant Staphylococcus aureus Colonization in a Random Sample of Healthy Individuals JY Rim, AE Bacon Infection Control & Hospital Epidemiology 28 (9), 1044-1046, 2007 | 50 | 2007 |
| Systematic literature review of the economic burden of celiac disease ES Mearns, A Taylor, T Boulanger, KJ Craig, M Gerber, DA Leffler, ... Pharmacoeconomics 37, 45-61, 2019 | 45 | 2019 |
| Plasma catecholamine profile of subarachnoid hemorrhage patients with neurogenic cardiomyopathy M Moussouttas, E Mearns, A Walters, M DeCaro Cerebrovascular Diseases Extra 5 (2), 57-67, 2015 | 35 | 2015 |
| Comparative cost and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers C Waycaster, MJ Carter, AM Gilligan, ES Mearns, CE Fife, CT Milne Journal of comparative effectiveness research 7 (2), 149-165, 2018 | 32 | 2018 |
| Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes WJ Saulsberry, CI Coleman, ES Mearns, E Zaccaro, Y Doleh, ... International journal of clinical practice 69 (11), 1221-1235, 2015 | 29 | 2015 |
| Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials ES Mearns, CI Coleman, D Patel, WJ Saulsberry, A Corman, D Li, ... Journal of Thrombosis and Haemostasis 13 (6), 1043-1052, 2015 | 25 | 2015 |
| Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US ES Mearns, M Liang, BL Limone, AM Gilligan, JD Miller, KD Schaum, ... ClinicoEconomics and Outcomes Research, 485-494, 2017 | 22 | 2017 |
| A review of US drug costs relevant to medicare, medicaid, and commercial insurers post-affordable care act enactment, 2010–2016 J McRae, FR Vogenberg, SW Beaty, E Mearns, S Varga, L Pizzi Pharmacoeconomics 35, 215-223, 2017 | 20 | 2017 |
| Cost‐Effectiveness of High‐Dose Edoxaban Compared with Adjusted‐Dose Warfarin for Stroke Prevention in Non–Valvular Atrial Fibrillation Patients E Nguyen, F Egri, ES Mearns, CM White, CI Coleman Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (5 …, 2016 | 20 | 2016 |
| Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review ES Mearns, JA Bell, A Galaznik, SM Puglielli, AB Cichewicz, T Boulanger, ... Melanoma Management 5 (1), MMT01, 2018 | 11 | 2018 |
| Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation BL Limone, WL Baker, ES Mearns, CM White, J Kluger, CI Coleman Journal of Clinical Epidemiology 67 (10), 1093-1102, 2014 | 11 | 2014 |
| Prognostic scores for acute pulmonary embolism R Morillo, L Moores, D Jiménez Seminars in Thrombosis and Hemostasis 43 (05), 486-492, 2017 | 9 | 2017 |
Craig I. ColemanUniversity of ConnecticutGeverifieerd e-mailadres voor harthosp.org
